Items where Research Centre is "Vaccine Centre"

Jump to: 2003
Number of items: 47.
2003
Aaby, Peter;
Jensen, Henrik;
Samb, Badara;
Cisse, Badara;
Sodemann, Morten;
Jakobsen, Marianne;
Poulsen, Anja;
Rodrigues, Amabelia;
Lisse, Ida Maria;
Simondon, Francois;
+1 more...
Whittle, Hilton;
(2003)
Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.
Lancet, 361 (9376).
pp. 2183-2188.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(03)13771-3
Full text not available from this repository.
Abebe, A;
Nokes, DJ;
Dejene, A;
Enquselassie, F;
Messele, T;
Cutts, FT;
(2003)
Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control.
Epidemiology and infection, 131 (1).
pp. 757-770.
ISSN 0950-2688
DOI: https://doi.org/10.1017/s0950268803008574
Ali, Mohammad;
Canh, Do Gia;
Clemens, John D;
Park, Jin-Kyung;
von Seidlein, Lorenz;
Thiem, Vu Dinh;
Tho, Le Huu;
Trach, Dang Duc;
(2003)
The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations.
Vaccine, 21 (15).
pp. 1681-1686.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(02)00633-3
Full text not available from this repository.
Allan, Elaine;
Wren, Brendan W;
(2003)
Genes to genetic immunization: identification of bacterial vaccine candidates.
Methods (San Diego, Calif), 31 (3).
pp. 193-198.
ISSN 1046-2023
DOI: https://doi.org/10.1016/s1046-2023(03)00133-6
Full text not available from this repository.
Alloueche, Ali;
Milligan, Paul;
Conway, David J;
Pinder, Margaret;
Bojang, Kalifa;
Doherty, Tom;
Tornieporth, Nadia;
Cohen, Joe;
Greenwood, Brian M;
(2003)
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.
The American journal of tropical medicine and hygiene, 68 (1).
pp. 97-101.
ISSN 0002-9637
DOI: https://doi.org/10.4269/ajtmh.2003.68.97
Armah, George E;
Steele, Andrew Duncan;
Binka, Fred N;
Esona, Mathew D;
Asmah, Richard Harry;
Anto, Francis;
Brown, David;
Green, Jon;
Cutts, Felicity;
Hall, Andy;
(2003)
Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children.
Journal of clinical microbiology, 41 (6).
pp. 2317-2322.
ISSN 0095-1137
DOI: https://doi.org/10.1128/JCM.41.6.2317-2322.2003
Full text not available from this repository.
Aylward, R Bruce;
Acharya, Arnab;
England, Sarah;
Agocs, Mary;
Linkins, Jennifer;
(2003)
Global health goals: lessons from the worldwide effort to eradicate poliomyelitis.
Lancet, 362 (9387).
pp. 909-914.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(03)14337-1
Full text not available from this repository.
Black, Gillian F;
Weir, Rosemary E;
Chaguluka, Steven D;
Warndorff, David;
Crampin, Amelia C;
Mwaungulu, Lorren;
Sichali, Lifted;
Floyd, Sian;
Bliss, Lyn;
Jarman, Elizabeth;
+10 more...
Donovan, Linda;
Andersen, Peter;
Britton, Warwick;
Hewinson, Glyn;
Huygen, Kris;
Paulsen, Jens;
Singh, Mahavir;
Prestidge, Ross;
Fine, Paul EM;
Dockrell, Hazel M;
(2003)
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
Clinical and diagnostic laboratory immunology, 10 (4).
pp. 602-611.
ISSN 1071-412X
DOI: https://doi.org/10.1128/cdli.10.4.602-611.2003
Full text not available from this repository.
Brisson, M;
Edmunds, WJ;
(2003)
Economic evaluation of vaccination programs: the impact of herd-immunity.
Medical decision making, 23 (1).
pp. 76-82.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X02239651
Full text not available from this repository.
Brisson, M;
Edmunds, WJ;
(2003)
Epidemiology of Varicella-Zoster Virus in England and Wales.
Journal of medical virology, 70 Sup (S1).
S9-14.
ISSN 0146-6615
DOI: https://doi.org/10.1002/jmv.10313
Full text not available from this repository.
Brisson, M;
Edmunds, WJ;
(2003)
Varicella vaccination in England and Wales: cost-utility analysis.
Archives of disease in childhood, 88 (10).
pp. 862-869.
ISSN 0003-9888
DOI: https://doi.org/10.1136/adc.88.10.862
Full text not available from this repository.
Brisson, M;
Edmunds, WJ;
Gay, NJ;
(2003)
Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.
Journal of medical virology, 70 Sup (S1).
S31-S37.
ISSN 0146-6615
DOI: https://doi.org/10.1002/jmv.10317
Full text not available from this repository.
Carabin, H;
Edmunds, WJ;
Gyldmark, M;
Beutels, P;
Lévy-Bruhl, D;
Salo, H;
Griffiths, UK;
(2003)
The cost of measles in industrialised countries.
Vaccine, 21 (27-30).
pp. 4167-4177.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(03)00534-6
Full text not available from this repository.
Carabin, Hélène;
Edmunds, W John;
(2003)
Future savings from measles eradication in industrialized countries.
The Journal of infectious diseases, 187 Su (s1).
S29-S35.
ISSN 0022-1899
DOI: https://doi.org/10.1086/368038
Full text not available from this repository.
Couper, Kevin N;
Nielsen, Henrik V;
Petersen, Eskild;
Roberts, Fiona;
Roberts, Craig W;
Alexander, James;
(2003)
DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission.
Vaccine, 21 (21-22).
pp. 2813-2820.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(03)00163-4
Full text not available from this repository.
Crook, Paul D;
Jones, Michael E;
Hall, Andrew J;
(2003)
Mortality of hepatitis B surface antigen-positive blood donors in England and Wales.
International journal of epidemiology, 32 (1).
pp. 118-124.
ISSN 0300-5771
DOI: https://doi.org/10.1093/ije/dyg039
Full text not available from this repository.
Cumberland, P;
Sethi, D;
Roderick, PJ;
Wheeler, JG;
Cowden, JM;
Roberts, JA;
Rodrigues, LC;
Hudson, MJ;
Tompkins, DS;
IID Study Executive;
(2003)
The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode.
Epidemiology and infection, 130 (3).
pp. 453-460.
ISSN 0950-2688
DOI: https://doi.org/10.1017/s0950268803008410
Cutts, FT;
Fine, PEM;
(2003)
Caution--mortality ratios ahead.
Lancet, 361 (9376).
pp. 2169-2170.
ISSN 0140-6736
DOI: https://doi.org/10.1016/s0140-6736(03)13783-x
Full text not available from this repository.
Dourado, I;
Rios, MH;
Pereira, SMM;
Cunha, SS;
Ichihara, MY;
Goes, JCL;
Rodrigues, LC;
Bierrenbach, AL;
Barreto, ML;
(2003)
Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren.
The international journal of tuberculosis and lung disease, 7 (4).
pp. 399-402.
ISSN 1027-3719
https://researchonline.lshtm.ac.uk/id/eprint/16536
Full text not available from this repository.
Enquselassie, F;
Ayele, W;
Dejene, A;
Messele, T;
Abebe, A;
Cutts, FT;
Nokes, DJ;
(2003)
Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.
Epidemiology and infection, 130 (3).
pp. 507-519.
ISSN 0950-2688
DOI: https://doi.org/10.1017/s0950268803008446
Fine, Paul EM;
(2003)
Commentary: Non-specific effects of measles vaccine--more grist for the mill.
International journal of epidemiology, 32 (1).
pp. 116-117.
ISSN 0300-5771
DOI: https://doi.org/10.1093/ije/dyg031
Full text not available from this repository.
Foynes, Susan;
Holley, Jane L;
Garmory, Helen S;
Titball, Richard W;
Fairweather, Neil F;
(2003)
Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
Vaccine, 21 (11-12).
pp. 1052-1059.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(02)00622-9
Full text not available from this repository.
French, Neil;
(2003)
Use of pneumococcal polysaccharide vaccines: no simple answers.
The Journal of infection, 46 (2).
pp. 78-86.
ISSN 0163-4453
DOI: https://doi.org/10.1053/jinf.2002.1113
Full text not available from this repository.
Garmory, Helen S;
Griffin, Kate F;
Brown, Katherine A;
Titball, Richard W;
(2003)
Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague.
Vaccine, 21 (21-22).
pp. 3051-3057.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(03)00112-9
Full text not available from this repository.
Garmory, Helen S;
Leary, Sophie EC;
Griffin, Kate F;
Williamson, E Diane;
Brown, Katherine A;
Titball, Richard W;
(2003)
The use of live attenuated bacteria as a delivery system for heterologous antigens.
Journal of drug targeting, 11 (8-10).
pp. 471-479.
ISSN 1061-186X
DOI: https://doi.org/10.1080/10611860410001670008
Full text not available from this repository.
Greenwood, Brian;
(2003)
Maternal immunisation in developing countries.
Vaccine, 21 (24).
pp. 3436-3441.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(03)00346-3
Full text not available from this repository.
Hall, Andrew J;
(2003)
Vaccination politics.
Tropical medicine & international health, 8 (1).
pp. 1-2.
ISSN 1360-2276
DOI: https://doi.org/10.1046/j.1365-3156.2003.00985.x
Full text not available from this repository.
Hall, Andrew J;
Wild, Christopher P;
(2003)
Liver cancer in low and middle income countries.
BMJ (Clinical research ed), 326 (7397).
pp. 994-995.
ISSN 0959-8138
DOI: https://doi.org/10.1136/bmj.326.7397.994
Hoveyda, N;
Behrens, Ron;
(2003)
More travel advice and fewer vaccinations are needed.
BMJ, 326 (7379).
52-.
ISSN 1468-5833
DOI: https://doi.org/10.1136/bmj.326.7379.52/a
Jaffar, Shabbar;
Leach, Amanda;
Smith, Peter G;
Cutts, Felicity;
Greenwood, Brian;
(2003)
Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia.
International journal of epidemiology, 32 (3).
pp. 430-436.
ISSN 0300-5771
DOI: https://doi.org/10.1093/ije/dyg082
Full text not available from this repository.
Jansen, VAA;
Stollenwerk, N;
Jensen, HJ;
Ramsay, ME;
Edmunds, WJ;
Rhodes, CJ;
(2003)
Measles outbreaks in a population with declining vaccine uptake.
Science (New York, NY), 301 (5634).
804-.
ISSN 0036-8075
DOI: https://doi.org/10.1126/science.1086726
Full text not available from this repository.
Kamil, AA;
Khalil, EAG;
Musa, AM;
Modabber, F;
Mukhtar, MM;
Ibrahim, ME;
Zijlstra, EE;
Sacks, D;
Smith, PG;
Zicker, F;
+1 more...
El-Hassan, AM;
(2003)
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 97 (3).
pp. 365-368.
ISSN 0035-9203
DOI: https://doi.org/10.1016/s0035-9203(03)90171-4
Full text not available from this repository.
Kimbi, Helen K;
Tetteh, Kevin KA;
Polley, Spencer D;
Conway, David J;
(2003)
Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 98 (5).
pp. 284-289.
ISSN 0035-9203
DOI: https://doi.org/10.1016/S0035-9203(03)00068-3
Full text not available from this repository.
Mangtani, Punam;
Cutts, Felicity;
Hall, Andrew J;
(2003)
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence.
The Lancet infectious diseases, 3 (2).
pp. 71-78.
ISSN 1473-3099
DOI: https://doi.org/10.1016/s1473-3099(03)00514-0
Full text not available from this repository.
Mangtani, Punam;
Hall, Andrew J;
Cutts, Felicity;
(2003)
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence.
The Lancet infectious diseases, 3 (5).
pp. 273-274.
ISSN 1473-3099
DOI: https://doi.org/10.1016/s1473-3099(03)00605-4
Full text not available from this repository.
Mbopi-Kéou, Francois-Xavier;
Bélec, Laurent;
Dalessio, Julie;
Legoff, Jérôme;
Grésenguet, Gérard;
Mayaud, Philippe;
Brown, David WG;
Morrow, Rhoda Ashley;
(2003)
Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.
Clinical and diagnostic laboratory immunology, 10 (3).
pp. 388-393.
ISSN 1071-412X
DOI: https://doi.org/10.1128/cdli.10.3.388-393.2003
Full text not available from this repository.
Morgan, OW;
Meltzer, M;
Muir, D;
Hogan, H;
Seng, C;
Hill, J;
Beckford, J;
(2003)
Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
Communicable disease and public health / PHLS, 6 (4).
pp. 330-333.
ISSN 1462-1843
https://researchonline.lshtm.ac.uk/id/eprint/13175
Full text not available from this repository.
Nardone, A;
Pebody, RG;
van den Hof, S;
Levy-Bruhl, D;
Plesner, AM;
Rota, MC;
Tischer, A;
Andrews, N;
Berbers, G;
Crovari, P;
+4 more...
Edmunds, WJ;
Gabutti, G;
Saliou, P;
Miller, E;
(2003)
Sero-epidemiology of mumps in western Europe.
Epidemiology and infection, 131 (1).
pp. 691-701.
ISSN 0950-2688
DOI: https://doi.org/10.1017/s0950268803008768
O'Brien, Katherine L;
Nohynek, Hanna;
World Health Organization Pneumococcal Vaccine Trials Carraige W;
(2003)
Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.
The Pediatric infectious disease journal, 22 (2).
pp. 133-140.
ISSN 0891-3668
DOI: https://doi.org/10.1097/01.inf.0000048676.93549.d1
Full text not available from this repository.
Pantosti, Annalisa;
Boccia, Delia;
D'Ambrosio, Fabio;
Recchia, Simona;
Orefici, Graziella;
Moro, Maria Luisa;
National Surveillance of Bacterial Meningitis;
Earss-Italia Study;
(2003)
Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
Microbial drug resistance (Larchmont, NY), 9 Supp (supple).
S61-S68.
ISSN 1076-6294
DOI: https://doi.org/10.1089/107662903322541919
Full text not available from this repository.
Perrett, K;
Granerød, J;
Crowcroft, N;
Carlisle, R;
(2003)
Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users?
Communicable disease and public health / PHLS, 6 (2).
pp. 97-100.
ISSN 1462-1843
https://researchonline.lshtm.ac.uk/id/eprint/8974
Full text not available from this repository.
Polley, Spencer D;
Chokejindachai, Watcharee;
Conway, David J;
(2003)
Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen.
Genetics, 165 (2).
pp. 555-561.
ISSN 0016-6731
DOI: https://doi.org/10.1093/genetics/165.2.555
Full text not available from this repository.
Polley, Spencer D;
Tetteh, Kevin KA;
Cavanagh, David R;
Pearce, Richard J;
Lloyd, Jennifer M;
Bojang, Kalifa A;
Okenu, Daniel MN;
Greenwood, Brian M;
McBride, Jana S;
Conway, David J;
(2003)
Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.
Infection and immunity, 71 (4).
pp. 1833-1842.
ISSN 0019-9567
DOI: https://doi.org/10.1128/IAI.71.4.1833-1842.2003
Full text not available from this repository.
Rhodes, Scott D;
Yee, Leland J;
Hergenrather, Kenneth C;
(2003)
Hepatitis A vaccination among young African American men who have sex with men in the deep south: psychosocial predictors.
Journal of the National Medical Association, 95 (4 Supp).
31S-36S.
ISSN 0027-9684
https://researchonline.lshtm.ac.uk/id/eprint/16067
Full text not available from this repository.
Roy, P;
(2003)
Nature and duration of protective immunity to bluetongue virus infection.
Developments in biologicals, 114.
pp. 169-183.
ISSN 1424-6074
https://researchonline.lshtm.ac.uk/id/eprint/15155
Full text not available from this repository.
Russell, FM;
Carapetis, JR;
Mansoor, O;
Darcy, A;
Fakakovi, T;
Metai, A;
Potoi, NT;
Wilson, N;
Mulholland, EK;
(2003)
High incidence of Haemophilus influenzae type b infection in children in Pacific island countries.
Clinical infectious diseases, 37 (12).
pp. 1593-1599.
ISSN 1058-4838
DOI: https://doi.org/10.1086/379717
Full text not available from this repository.
Vynnycky, E;
Gay, NJ;
Cutts, FT;
(2003)
The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome.
Vaccine, 21 (21-22).
pp. 2708-2719.
ISSN 0264-410X
DOI: https://doi.org/10.1016/s0264-410x(03)00229-9
Full text not available from this repository.